Surgical Science Sweden AB (publ) (SUS.ST)
SEK 154.5
(0.85%)
SEK 154.5
(0.85%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 558.88 Million SEK | 5.15% |
| 2022 | 531.51 Million SEK | 99.86% |
| 2021 | 265.94 Million SEK | 200.96% |
| 2020 | 88.36 Million SEK | 5.72% |
| 2019 | 83.58 Million SEK | 16.21% |
| 2018 | 71.91 Million SEK | 15.78% |
| 2017 | 62.11 Million SEK | 6.92% |
| 2016 | 58.1 Million SEK | 10.88% |
| 2015 | 52.4 Million SEK | 128.49% |
| 2014 | 22.93 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 108.95 Million SEK | -26.78% |
| 2024 Q2 | 129.55 Million SEK | 18.9% |
| 2023 Q3 | 145.02 Million SEK | -1.17% |
| 2023 FY | 558.88 Million SEK | 5.15% |
| 2023 Q1 | 158.68 Million SEK | -3.39% |
| 2023 Q2 | 146.73 Million SEK | -7.53% |
| 2023 Q4 | 148.8 Million SEK | 2.6% |
| 2022 Q1 | 102.77 Million SEK | -23.5% |
| 2022 FY | 531.51 Million SEK | 99.86% |
| 2022 Q4 | 164.24 Million SEK | 19.6% |
| 2022 Q3 | 137.33 Million SEK | 8.0% |
| 2022 Q2 | 127.16 Million SEK | 23.73% |
| 2021 Q2 | 31.53 Million SEK | 1.18% |
| 2021 Q1 | 31.16 Million SEK | -4.19% |
| 2021 FY | 265.94 Million SEK | 200.96% |
| 2021 Q4 | 134.34 Million SEK | 94.95% |
| 2021 Q3 | 68.9 Million SEK | 118.55% |
| 2020 Q1 | 16.46 Million SEK | -50.04% |
| 2020 Q3 | 21.51 Million SEK | 20.4% |
| 2020 Q4 | 32.52 Million SEK | 51.2% |
| 2020 FY | 88.36 Million SEK | 5.72% |
| 2020 Q2 | 17.86 Million SEK | 8.53% |
| 2019 Q1 | 10.39 Million SEK | -61.11% |
| 2019 FY | 83.58 Million SEK | 16.21% |
| 2019 Q3 | 28.03 Million SEK | 129.87% |
| 2019 Q4 | 32.95 Million SEK | 17.52% |
| 2019 Q2 | 12.19 Million SEK | 17.39% |
| 2018 Q2 | 16.8 Million SEK | 29.23% |
| 2018 FY | 71.91 Million SEK | 15.78% |
| 2018 Q3 | 15.2 Million SEK | -9.52% |
| 2018 Q4 | 26.71 Million SEK | 75.78% |
| 2018 Q1 | 13 Million SEK | -47.83% |
| 2017 Q4 | 24.91 Million SEK | 122.49% |
| 2017 Q1 | 12.8 Million SEK | -53.45% |
| 2017 FY | 62.11 Million SEK | 6.92% |
| 2017 Q2 | 13.2 Million SEK | 3.13% |
| 2017 Q3 | 11.2 Million SEK | -15.15% |
| 2016 Q2 | 12.2 Million SEK | 1.67% |
| 2016 Q1 | 12 Million SEK | 0.0% |
| 2016 Q3 | 6.4 Million SEK | -47.54% |
| 2016 FY | 58.1 Million SEK | 10.88% |
| 2016 Q4 | 27.5 Million SEK | 329.69% |
| 2015 FY | 52.4 Million SEK | 128.49% |
| 2014 FY | 22.93 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aino Health AB (publ) | 3.79 Million SEK | -14615.298% |
| Bonzun AB (publ) | -25.25 Million SEK | 2312.977% |
| Kontigo Care AB (publ) | 2.74 Million SEK | -20252.768% |
| Medhelp Care Aktiebolag (publ) | 90.38 Million SEK | -518.327% |
| RaySearch Laboratories AB (publ) | 630.37 Million SEK | 11.341% |